Poacic Acid is a plant-derived stilbenoid with an antifungal activity. Poacic Acid localizes to the yeast cell wall and disrupts the production and assembly of β-1,3-glucan in the fungal cell walls. Poacic Acid exhibits fungicidal activity to Saccharomyces cerevisiae and plasma membrane-compromised Candida albicans mutants[1].

POC1A Human Pre-designed siRNA Set A contains three designed siRNAs for POC1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POC1B Human Pre-designed siRNA Set A contains three designed siRNAs for POC1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POC5 Human Pre-designed siRNA Set A contains three designed siRNAs for POC5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PODN Human Pre-designed siRNA Set A contains three designed siRNAs for PODN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PODXL Human Pre-designed siRNA Set A contains three designed siRNAs for PODXL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PODXL2 Human Pre-designed siRNA Set A contains three designed siRNAs for PODXL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POF1B Human Pre-designed siRNA Set A contains three designed siRNAs for POF1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POFUT1 Human Pre-designed siRNA Set A contains three designed siRNAs for POFUT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POFUT2 Human Pre-designed siRNA Set A contains three designed siRNAs for POFUT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POGK Human Pre-designed siRNA Set A contains three designed siRNAs for POGK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POGLUT1 Human Pre-designed siRNA Set A contains three designed siRNAs for POGLUT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POGZ Human Pre-designed siRNA Set A contains three designed siRNAs for POGZ gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLA1 Human Pre-designed siRNA Set A contains three designed siRNAs for POLA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLA2 Human Pre-designed siRNA Set A contains three designed siRNAs for POLA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLB Human Pre-designed siRNA Set A contains three designed siRNAs for POLB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLD1 Human Pre-designed siRNA Set A contains three designed siRNAs for POLD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLD2 Human Pre-designed siRNA Set A contains three designed siRNAs for POLD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLD3 Human Pre-designed siRNA Set A contains three designed siRNAs for POLD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLD4 Human Pre-designed siRNA Set A contains three designed siRNAs for POLD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLDIP2 Human Pre-designed siRNA Set A contains three designed siRNAs for POLDIP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLDIP3 Human Pre-designed siRNA Set A contains three designed siRNAs for POLDIP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLE Human Pre-designed siRNA Set A contains three designed siRNAs for POLE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLE2 Human Pre-designed siRNA Set A contains three designed siRNAs for POLE2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLE3 Human Pre-designed siRNA Set A contains three designed siRNAs for POLE3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLE4 Human Pre-designed siRNA Set A contains three designed siRNAs for POLE4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLG Human Pre-designed siRNA Set A contains three designed siRNAs for POLG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLG2 Human Pre-designed siRNA Set A contains three designed siRNAs for POLG2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLH Human Pre-designed siRNA Set A contains three designed siRNAs for POLH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLI Human Pre-designed siRNA Set A contains three designed siRNAs for POLI gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLK Human Pre-designed siRNA Set A contains three designed siRNAs for POLK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLM Human Pre-designed siRNA Set A contains three designed siRNAs for POLM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

POLN Human Pre-designed siRNA Set A contains three designed siRNAs for POLN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Poloxamer 101 L31 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 1100. Poloxamer 101 L31 forms hydrogel, that is utilized as surfactants and emulsifying agents. Poloxamer 101 L31 induces slight alveolitis[1].

Poloxamer 105 L35 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 1900. Poloxamer 105 L35 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering[1].

Poloxamer 122 L42 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 1630. Poloxamer 122 L42 exhibits antimicrobial activity, that inihibits 56% Mycobacterium avium complex at concentration of 1 mg/mL. Poloxamer 122 L42 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering[1][2].

Poloxamer 123 L43 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 1850. Poloxamer 123 L43 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering[1].

Poloxamer 124 L44 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 2200. Poloxamer 124 L44 reveals toxicity with an oral LD50 of 5 g/kg in albino rats. Poloxamer 124 L44 causes ocular irritation. Poloxamer 124 L44 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical […]

Poloxamer 125 L45 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 2400. Poloxamer 125 L45 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering[1].

Poloxamer 181 L61 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 2000. Poloxamer 181 L61 exhibits antimicrobial activity, that inihibits 91% Mycobacterium avium complex at concentration of 1 mg/mL. Poloxamer 181 L61 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering[1][2].

Poloxamer 183 L63 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 2650. Poloxamer 183 L63 exhibits antimicrobial activity, that inihibits 83% Mycobacterium avium complex at concentration of 1 mg/mL. Poloxamer 183 L63 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering[1][2].

Poloxamer 184 L64 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 2900. Poloxamer 184 L64 exhibts short-term dermal toxicity characterized by slight erythema and intradermal inflammatory response. Poloxamer 184 L64 exhibits antimicrobial activity, that inihibits 60% Mycobacterium avium complex at concentration of 1 mg/mL. Poloxamer 184 L64 forms thermoreversible hydrogel, that […]

Poloxamer 185 P65 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 3400. Poloxamer 185 P65 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering[1].

Poloxamer 212 L72 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 2750. Poloxamer 212 L72 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering[1].

Poloxamer 215 P75 is block polymer of polyoxyethylene and polyoxypropylene with average molecular mass of 4150. Poloxamer 215 P75 forms thermoreversible hydrogel, that is utilized in food additives, drug delivery carriers in cosmetics, pharmaceutical ingredients and tissue engineering[1].